134 related articles for article (PubMed ID: 37787784)
1. Anti-proliferative activity of chitosan-coated oxypeucedanin nano-chitosomes (COPD-NCs) against human HT-29 colon cancer cells: in vitro study.
Almohammed MAO; Meshkani S; Homayouni Tabrizi M; Sharbatiyan M; Nasiraei Haghighi H
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2133-2143. PubMed ID: 37787784
[TBL] [Abstract][Full Text] [Related]
2. Synthesis Folate-linked Chitosan-coated Quetiapine/BSA Nano-Carriers as the Efficient Targeted Anti-Cancer Drug Delivery System.
Al-Hasnawi HNG; Pouresmaeil V; Davoodi-Dehaghani F; Rahban S; Pouresmaeil A; Homayouni Tabrizi M
Mol Biotechnol; 2023 Aug; ():. PubMed ID: 37633875
[TBL] [Abstract][Full Text] [Related]
3. The folate-linked chitosan-coated Kaempferol/HSA nano-transporters (FCKH-NTs) as the selective apoptotic inducer in human MCF-7 breast cancer cell line.
Mollaei M; Homayouni Tabrizi M; Es-Haghi A
Drug Dev Ind Pharm; 2023 Oct; 49(10):658-665. PubMed ID: 37814890
[TBL] [Abstract][Full Text] [Related]
4. The anticancer, anti-oxidant, and antibacterial activities of chitosan-lecithin-coated parthenolide/tyrosol hybrid nanoparticles.
Bahrani HMH; Ghobeh M; Homayouni Tabrizi M
J Biomater Sci Polym Ed; 2023 Aug; 34(11):1603-1617. PubMed ID: 36755525
[TBL] [Abstract][Full Text] [Related]
5. The antioxidant, anti-angiogenic, and anticancer impact of chitosan-coated herniarin-graphene oxide nanoparticles (CHG-NPs).
Jasim LMM; Homayouni Tabrizi M; Darabi E; Jaseem MMM
Heliyon; 2023 Sep; 9(9):e20042. PubMed ID: 37809932
[TBL] [Abstract][Full Text] [Related]
6.
Al-Harmooshee AHW; Homayouni Tabrizi M; Hayati Roodbari N
Iran J Basic Med Sci; 2024; 27(2):180-187. PubMed ID: 38234667
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of designed PLGA-arctiin nanoparticles modified with folic acid and chitosan on colon cancer cells.
Alhadidi MHA; Tabrizi MH; Ghobeh M
Biotechnol Appl Biochem; 2024 Feb; 71(1):72-80. PubMed ID: 37817403
[TBL] [Abstract][Full Text] [Related]
8. PLGA-Based Nano-Encapsulation of
Almnhawy M; Jebur M; Alhajamee M; Marai K; Tabrizi MH
Nutr Cancer; 2021; 73(11-12):2808-2820. PubMed ID: 33319599
[TBL] [Abstract][Full Text] [Related]
9. Fabrication and assessment of folic acid conjugated-chitosan modified PLGA nanoparticle for delivery of alpha terpineol in colon cancer.
Rahmati A; Homayouni Tabrizi M; Karimi E; Zarei B
J Biomater Sci Polym Ed; 2022 Jul; 33(10):1289-1307. PubMed ID: 35260045
[TBL] [Abstract][Full Text] [Related]
10. Nanofabrication of PLGA-PEG-chitosan-folic acid systems for delivery of colchicine to HT-29 cancer cells.
Sadeghzadeh F; Ziaratnia AS; Homayouni Tabrizi M; Torshizi GH; Alhajamee M; Khademi D
J Biomater Sci Polym Ed; 2023 Jan; 34(1):1-17. PubMed ID: 35864733
[TBL] [Abstract][Full Text] [Related]
11. Effects of solid lipid nanocarrier containing methyl urolithin A by coating folate-bound chitosan and evaluation of its anti-cancer activity.
Al-Fatlawi INAA; Pouresmaeil V; Davoodi-Dehaghani F; Pouresmaeil A; Akhtari A; Tabrizi MH
BMC Biotechnol; 2024 Apr; 24(1):18. PubMed ID: 38600497
[TBL] [Abstract][Full Text] [Related]
12. The urolithin B nanomicellar delivery system as an efficient selective anticancer compound.
Albuthyab NOM; Hosseini H; Homayouni Tabrizi M; Kharaghani M; Saghravanian SS
Mol Biol Rep; 2024 Jan; 51(1):85. PubMed ID: 38183506
[TBL] [Abstract][Full Text] [Related]
13. Preparation and Characterization of Novel Polyelectrolyte Liposomes Using Chitosan Succinate Layered over Chitosomes: A Potential Strategy for Colon Cancer Treatment.
Yosef AM; Alqarni RS; Sayd FY; Alhawiti MS; Almahlawi RM; Prabahar K; Uthumansha U; Alanazi MA; El-Sherbiny M; Elsherbiny N; Qushawy M
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255231
[TBL] [Abstract][Full Text] [Related]
14. The Lawson-loaded β-cyclodextrin nanocarriers (LB-NCs) a novel targeted cancer cell in stomach and breast cancer as a drug delivery system.
Alboabdullah AKA; Goodarzi MT; Homayouni Tabrizi M
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; ():. PubMed ID: 38483577
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of folic acid-conjugated chitosan-coated PLGA nanoparticles for targeted delivery of
Homayouni Tabrizi M
Nanotechnology; 2022 Sep; 33(49):. PubMed ID: 36121718
[TBL] [Abstract][Full Text] [Related]
16. Decrypting the Molecular Mechanistic Pathways Delineating the Chemotherapeutic Potential of Ruthenium-Phloretin Complex in Colon Carcinoma Correlated with the Oxidative Status and Increased Apoptotic Events.
Jin G; Zhao Z; Chakraborty T; Mandal A; Roy A; Roy S; Guo Z
Oxid Med Cell Longev; 2020; 2020():7690845. PubMed ID: 32566099
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological Evaluation of Aldehydic-Pyrrolidinedione Against HCT-116, MDA-MB231, NIH/3T3, MCF-7 Cancer Cell Lines, Antioxidant and Enzyme Inhibition Studies.
Ahmad A; Ullah F; Sadiq A; Ayaz M; Rahim H; Rashid U; Ahmad S; Jan MS; Ullah R; Shahat AA; Mahmood HM
Drug Des Devel Ther; 2019; 13():4185-4194. PubMed ID: 31849450
[TBL] [Abstract][Full Text] [Related]
18. Increased ROS Scavenging and Antioxidant Efficiency of Chlorogenic Acid Compound Delivered via a Chitosan Nanoparticulate System for Efficient In Vitro Visualization and Accumulation in Human Renal Adenocarcinoma Cells.
Kavi Rajan R; Hussein MZ; Fakurazi S; Yusoff K; Masarudin MJ
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547100
[TBL] [Abstract][Full Text] [Related]
19. Development of rosuvastatin flexible lipid-based nanoparticles: promising nanocarriers for improving intestinal cells cytotoxicity.
Ahmed TA
BMC Pharmacol Toxicol; 2020 Feb; 21(1):14. PubMed ID: 32085802
[TBL] [Abstract][Full Text] [Related]
20. Chemical investigation and screening of anti-cancer potential of
Abadi AVM; Karimi E; Oskoueian E; Mohammad GRKS; Shafaei N
3 Biotech; 2022 Feb; 12(2):49. PubMed ID: 35127304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
